Intestinal and multivisceral transplantation

Future perspectives

Gennaro Selvaggi, Andreas G. Tzakis

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The field of intestinal transplantation has experienced a progressive increase in patient and graft survival over the last few years, leading to a parallel increase in the number of programs performing such type of surgical procedures. Indications for intestinal transplant include irreversible intestinal failure, compounded by potential life-threatening complications such as loss of intravenous access, liver failure or multiple episodes of infections. The type of graft that is required is highly individualized according to the patient's original diagnosis and status. Presence of short gut syndrome alone is indication for isolated intestinal transplant; liver failure mandates the use of a liver graft (liver-intestine or multivisceral transplant); intestinal dysmotility disorders with intact liver function require the use of a modified multivisceral graft. Most of the current immunosuppression protocols consist in induction immunosuppression and maintenance doses of tacrolimus. Rejection and infectious complications remain the most common causes of morbidity and mortality; it is therefore essential to closely monitor the intestinal graft to prevent such occurrences. Future developments include: the use of non-invasive markers of rejection; a refinement in surgical techniques; development of advanced immunosuppression protocols; expansion of living related transplant and multivisceral transplantation in selected patients.

Original languageEnglish
Pages (from-to)4742-4754
Number of pages13
JournalFrontiers in Bioscience
Volume12
Issue number12
DOIs
StatePublished - May 1 2007

Fingerprint

Transplants
Grafts
Liver
Transplantation
Immunosuppression
Liver Failure
Transplantation (surgical)
Tacrolimus
Graft Survival
Intestines
Morbidity
Mortality
Infection

Keywords

  • Gastrointestinal tract
  • Intestine
  • Multivisceral transplantation
  • Review
  • Transplantation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Intestinal and multivisceral transplantation : Future perspectives. / Selvaggi, Gennaro; Tzakis, Andreas G.

In: Frontiers in Bioscience, Vol. 12, No. 12, 01.05.2007, p. 4742-4754.

Research output: Contribution to journalArticle

@article{a3cce13c8f1546f591eac0e3bfc80566,
title = "Intestinal and multivisceral transplantation: Future perspectives",
abstract = "The field of intestinal transplantation has experienced a progressive increase in patient and graft survival over the last few years, leading to a parallel increase in the number of programs performing such type of surgical procedures. Indications for intestinal transplant include irreversible intestinal failure, compounded by potential life-threatening complications such as loss of intravenous access, liver failure or multiple episodes of infections. The type of graft that is required is highly individualized according to the patient's original diagnosis and status. Presence of short gut syndrome alone is indication for isolated intestinal transplant; liver failure mandates the use of a liver graft (liver-intestine or multivisceral transplant); intestinal dysmotility disorders with intact liver function require the use of a modified multivisceral graft. Most of the current immunosuppression protocols consist in induction immunosuppression and maintenance doses of tacrolimus. Rejection and infectious complications remain the most common causes of morbidity and mortality; it is therefore essential to closely monitor the intestinal graft to prevent such occurrences. Future developments include: the use of non-invasive markers of rejection; a refinement in surgical techniques; development of advanced immunosuppression protocols; expansion of living related transplant and multivisceral transplantation in selected patients.",
keywords = "Gastrointestinal tract, Intestine, Multivisceral transplantation, Review, Transplantation",
author = "Gennaro Selvaggi and Tzakis, {Andreas G.}",
year = "2007",
month = "5",
day = "1",
doi = "10.2741/2423",
language = "English",
volume = "12",
pages = "4742--4754",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "12",

}

TY - JOUR

T1 - Intestinal and multivisceral transplantation

T2 - Future perspectives

AU - Selvaggi, Gennaro

AU - Tzakis, Andreas G.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - The field of intestinal transplantation has experienced a progressive increase in patient and graft survival over the last few years, leading to a parallel increase in the number of programs performing such type of surgical procedures. Indications for intestinal transplant include irreversible intestinal failure, compounded by potential life-threatening complications such as loss of intravenous access, liver failure or multiple episodes of infections. The type of graft that is required is highly individualized according to the patient's original diagnosis and status. Presence of short gut syndrome alone is indication for isolated intestinal transplant; liver failure mandates the use of a liver graft (liver-intestine or multivisceral transplant); intestinal dysmotility disorders with intact liver function require the use of a modified multivisceral graft. Most of the current immunosuppression protocols consist in induction immunosuppression and maintenance doses of tacrolimus. Rejection and infectious complications remain the most common causes of morbidity and mortality; it is therefore essential to closely monitor the intestinal graft to prevent such occurrences. Future developments include: the use of non-invasive markers of rejection; a refinement in surgical techniques; development of advanced immunosuppression protocols; expansion of living related transplant and multivisceral transplantation in selected patients.

AB - The field of intestinal transplantation has experienced a progressive increase in patient and graft survival over the last few years, leading to a parallel increase in the number of programs performing such type of surgical procedures. Indications for intestinal transplant include irreversible intestinal failure, compounded by potential life-threatening complications such as loss of intravenous access, liver failure or multiple episodes of infections. The type of graft that is required is highly individualized according to the patient's original diagnosis and status. Presence of short gut syndrome alone is indication for isolated intestinal transplant; liver failure mandates the use of a liver graft (liver-intestine or multivisceral transplant); intestinal dysmotility disorders with intact liver function require the use of a modified multivisceral graft. Most of the current immunosuppression protocols consist in induction immunosuppression and maintenance doses of tacrolimus. Rejection and infectious complications remain the most common causes of morbidity and mortality; it is therefore essential to closely monitor the intestinal graft to prevent such occurrences. Future developments include: the use of non-invasive markers of rejection; a refinement in surgical techniques; development of advanced immunosuppression protocols; expansion of living related transplant and multivisceral transplantation in selected patients.

KW - Gastrointestinal tract

KW - Intestine

KW - Multivisceral transplantation

KW - Review

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=34347215104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347215104&partnerID=8YFLogxK

U2 - 10.2741/2423

DO - 10.2741/2423

M3 - Article

VL - 12

SP - 4742

EP - 4754

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 12

ER -